Chicago Capital Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-147,000
Closed -$12.5M 23
2020
Q3
$12.5M Buy
+147,000
New +$7.43M 11.97% 5

Chicago Capital Management's IMMU Position: Q4 2020 in Review

Chicago Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 147,000 shares — an estimated $12.5M sold.

Chicago Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $12.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Chicago Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Chicago Capital Management sold 147,000 Immunomedics Inc shares in Q4 2020, an estimated $12.5M.
  • Chicago Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
  • Chicago Capital Management's Immunomedics Inc position peaked at $12.5M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Chicago Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.